Sign In
Buy CORT
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Corcept Therapeutics Appoints Gregg Alton to Board of Directors
12:00am, Thursday, 12'th Mar 2020Capital Impact Advisors LLC Boosts Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)
11:58am, Wednesday, 11'th Mar 2020
Capital Impact Advisors LLC boosted its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 4.6% during the fourth quarter, according to the company in its most recent Form 13F fi
Charles Schwab Investment Management Inc. Raises Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)
09:28am, Tuesday, 10'th Mar 2020
Charles Schwab Investment Management Inc. boosted its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 14.4% during the fourth quarter, Holdings Channel.com reports. The firm o
Chicago Equity Partners LLC Trims Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT)
11:14am, Saturday, 07'th Mar 2020
Chicago Equity Partners LLC lowered its position in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 52.5% during the 4th quarter, according to the company in its most recent disclosure with the Sec
Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 6.8%
08:44am, Saturday, 07'th Mar 2020
Corcept Therapeutics Incorporated (NASDAQ:CORT)’s share price fell 6.8% during trading on Friday . The company traded as low as $11.21 and last traded at $11.56, 1,924,214 shares changed hands durin
Mackay Shields LLC Invests $3.06 Million in Corcept Therapeutics Incorporated (NASDAQ:CORT)
01:56pm, Friday, 06'th Mar 2020
Mackay Shields LLC acquired a new position in Corcept Therapeutics Incorporated (NASDAQ:CORT) during the fourth quarter, according to the company in its most recent disclosure with the Securities and
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Purchased by Barclays PLC
10:58am, Friday, 06'th Mar 2020
Barclays PLC grew its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 95.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fu
Amgen Stock Strength Climbs Amid 'New Product Driven' Growth
05:21pm, Tuesday, 03'rd Mar 2020
"We are entering a period of new product driven revenue growth," Bradway said. "Heading into 2020, our capital allocation priorities are clear."
ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers
10:18pm, Monday, 02'nd Mar 2020
With one investigational cancer drug in Phase 1 testing and a second one approaching the clinic, ORIC Pharmaceuticals is looking to tap the public markets
Los Angeles Capital Management & Equity Research Inc. Buys Shares of 14,900 Corcept Therapeutics Incorporated (NASDAQ:CORT)
10:50am, Monday, 02'nd Mar 2020
Los Angeles Capital Management & Equity Research Inc. acquired a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) during the fourth quarter, according to its most recent 13F fili
$86.87 Million in Sales Expected for Corcept Therapeutics Incorporated (NASDAQ:CORT) This Quarter
09:00am, Sunday, 01'st Mar 2020
Brokerages forecast that Corcept Therapeutics Incorporated (NASDAQ:CORT) will post sales of $86.87 million for the current quarter, Zacks reports. Three analysts have issued estimates for Corcept Ther
Analysts Set Corcept Therapeutics Incorporated (NASDAQ:CORT) Target Price at $16.75
11:34am, Saturday, 29'th Feb 2020
Corcept Therapeutics Incorporated (NASDAQ:CORT) has been assigned an average recommendation of “Hold” from the seven analysts that are presently covering the firm, MarketBeat reports. One investme
FY2020 EPS Estimates for Corcept Therapeutics Incorporated (NASDAQ:CORT) Lifted by Cantor Fitzgerald
09:04am, Friday, 28'th Feb 2020
Corcept Therapeutics Incorporated (NASDAQ:CORT) – Equities researchers at Cantor Fitzgerald increased their FY2020 earnings estimates for shares of Corcept Therapeutics in a research report issued o
Corcept Therapeutics (NASDAQ:CORT) Lifted to Buy at BidaskClub
06:46am, Friday, 28'th Feb 2020
Corcept Therapeutics (NASDAQ:CORT) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued on Friday, BidAskClub reports. A number of
American International Group Inc. Cuts Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)
09:26am, Thursday, 27'th Feb 2020
American International Group Inc. reduced its position in Corcept Therapeutics Incorporated (NASDAQ:CORT) by 2.6% during the 4th quarter, according to its most recent filing with the Securities and Ex
